[
    {
        "title": "Should You Sell Acorda Therapeutics Inc (ACOR) in Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver",
        "description": "Should You Sell Acorda Therapeutics Inc (ACOR) in Drug Manufacturers - Specialty & Generic Industry?  InvestorsObserver",
        "published date": "Thu, 05 Oct 2023 14:51:29 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5pbnZlc3RvcnNvYnNlcnZlci5jb20vbmV3cy9zdG9jay11cGRhdGUvc2hvdWxkLXlvdS1zZWxsLWFjb3JkYS10aGVyYXBldXRpY3MtaW5jLWFjb3ItaW4tZHJ1Zy1tYW51ZmFjdHVyZXJzLXNwZWNpYWx0eS1nZW5lcmljLWluZHVzdHJ50gGVAWh0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3N0b2NrLXVwZGF0ZS9hbXAvc2hvdWxkLXlvdS1zZWxsLWFjb3JkYS10aGVyYXBldXRpY3MtaW5jLWFjb3ItaW4tZHJ1Zy1tYW51ZmFjdHVyZXJzLXNwZWNpYWx0eS1nZW5lcmljLWluZHVzdHJ5?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.investorsobserver.com",
            "title": "InvestorsObserver"
        }
    },
    {
        "title": "ENDX announce IEM Sydney Fantasy League, ENUK enters - Esports News UK",
        "description": "ENDX announce IEM Sydney Fantasy League, ENUK enters  Esports News UK",
        "published date": "Tue, 17 Oct 2023 23:46:59 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vZXNwb3J0cy1uZXdzLmNvLnVrLzIwMjMvMTAvMTgvZW5keC1pZW0tc3lkbmV5LWZhbnRhc3ktbGVhZ3VlL9IBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://esports-news.co.uk",
            "title": "Esports News UK"
        }
    },
    {
        "title": "Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split - Yahoo Finance",
        "description": "Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split  Yahoo Finance",
        "published date": "Fri, 02 Jun 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hY29yZGEtdGhlcmFwZXV0aWNzLWFubm91bmNlcy1jb21wbGV0aW9uLTEtMjAwMTAwMDg5Lmh0bWzSAWBodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9hY29yZGEtdGhlcmFwZXV0aWNzLWFubm91bmNlcy1jb21wbGV0aW9uLTEtMjAwMTAwMDg5Lmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "CORT: Time to Capitalize on These 3 Hot Biotech Stocks - StockNews.com",
        "description": "CORT: Time to Capitalize on These 3 Hot Biotech Stocks  StockNews.com",
        "published date": "Thu, 13 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2NvcnQtbGduZC1hY29yLXhiaS10aW1lLXRvLWNhcGl0YWxpemUtb24tdGhlc2UtMy1ob3QtYmlvdGVjaC1zdG9ja3Mv0gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://stocknews.com",
            "title": "StockNews.com"
        }
    },
    {
        "title": "Acorda: Q2 Earnings Snapshot - Yahoo Finance",
        "description": "Acorda: Q2 Earnings Snapshot  Yahoo Finance",
        "published date": "Tue, 08 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hY29yZGEtcTItZWFybmluZ3Mtc25hcHNob3QtMjAyMTAyMjIyLmh0bWzSAVFodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9hY29yZGEtcTItZWFybmluZ3Mtc25hcHNob3QtMjAyMTAyMjIyLmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "Oak Run Living: Oct. 13 | Lifestyle | chronicleonline.com - Citrus County Chronicle",
        "description": "Oak Run Living: Oct. 13 | Lifestyle | chronicleonline.com  Citrus County Chronicle",
        "published date": "Wed, 11 Oct 2023 02:51:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5jaHJvbmljbGVvbmxpbmUuY29tL3dlZWtsaWVzL21hcmlvbl9jaXRpemVuL2xpZmVzdHlsZS9vYWstcnVuLWxpdmluZy1vY3QtMTMvYXJ0aWNsZV8zMGVmZDRjOS1mYTExLTU5ZDEtYWEyMi03NTMxNjliMTU3NWMuaHRtbNIBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.chronicleonline.com",
            "title": "Citrus County Chronicle"
        }
    },
    {
        "title": "Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China - Yahoo Finance",
        "description": "Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China  Yahoo Finance",
        "published date": "Mon, 08 May 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hY29yZGEtdGhlcmFwZXV0aWNzLWNoYW5jZS1waGFybWFjZXV0aWNhbHMtYW5ub3VuY2UtMTEwMDAwNDU1Lmh0bWzSAWlodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9hY29yZGEtdGhlcmFwZXV0aWNzLWNoYW5jZS1waGFybWFjZXV0aWNhbHMtYW5ub3VuY2UtMTEwMDAwNDU1Lmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Acorda Therapeutics ( - Benzinga",
        "description": "Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Acorda Therapeutics (  Benzinga",
        "published date": "Thu, 08 Jun 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9uZXdzLzIzLzA2LzMyNzc2NzMzL3doeS1zZW10ZWNoLXNoYXJlcy1hcmUtdHJhZGluZy1oaWdoZXItYnktMjUtaGVyZS1hcmUtMjAtc3RvY2tzLW1vdmluZy1wcmVtYXJrZXTSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzI3NzY3MzM?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.benzinga.com",
            "title": "Benzinga"
        }
    },
    {
        "title": "Acorda Therapeutics Withdraws Proposal to Increase Authorized ... - Business Wire",
        "description": "Acorda Therapeutics Withdraws Proposal to Increase Authorized ...  Business Wire",
        "published date": "Mon, 10 Oct 2022 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiogFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMTAxMDAwNTIxMy9lbi9BY29yZGEtVGhlcmFwZXV0aWNzLVdpdGhkcmF3cy1Qcm9wb3NhbC10by1JbmNyZWFzZS1BdXRob3JpemVkLVNoYXJlcy1mcm9tLVNwZWNpYWwtTWVldGluZy1vZi1TdG9ja2hvbGRlcnPSAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.businesswire.com",
            "title": "Business Wire"
        }
    },
    {
        "title": "Acorda (ACOR) Down More Than 80% Year to Date: Here's Why - Yahoo Finance",
        "description": "Acorda (ACOR) Down More Than 80% Year to Date: Here's Why  Yahoo Finance",
        "published date": "Mon, 02 Dec 2019 08:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hY29yZGEtYWNvci1kb3duLW1vcmUtODAtMTUyMjAzMDgxLmh0bWzSAU5odHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9hY29yZGEtYWNvci1kb3duLW1vcmUtODAtMTUyMjAzMDgxLmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    }
]